MBOT News

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

MBOT

(NASDAQ:MBOT) $25.2 million in first closing and $4 million in second closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in full of short-term preferred investment options $25.2 million in first closing and $4 million in second closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in full of short-term preferred investment options

September 16, 2025Funding
Read more →

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

MBOT

With the Newly Granted IP, the Company’s IP Portfolio for the LIBERTY® System now includes 12 patents granted globally and 57 patent applications pending.

August 20, 2025Patents
Read more →

Microbot Medical Expands Commercial Team Ahead Of Anticipated Q3 2025 U.S. Launch of LIBERTY Robotic System; FDA 510(k) Decision Expected Q3 2025

MBOT

June 9, 2025
Read more →

Microbot Medical Secures Preliminary Inclusion To Russell Microcap Index

MBOT

June 5, 2025
Read more →

HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $9 Price Target

MBOT

April 10, 2025
Read more →

Microbot Medical Presented For Data For The First Time From Its ACCESS-PVI Trial At The Society Of Interventional Radiology Annual Meeting

MBOT

April 9, 2025
Read more →

Microbot Medical Announces Commencement Of GLP Pre-Clinical Trial

MBOT

September 12, 2022
Read more →